{"id":106378,"date":"2023-08-08T12:49:19","date_gmt":"2023-08-08T07:19:19","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=106378"},"modified":"2023-08-08T12:49:21","modified_gmt":"2023-08-08T07:19:21","slug":"pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/","title":{"rendered":"Pharma stock hits 20% upper circuit after company&#8217;s net profit increases by 147%"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-916684943\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#8217;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3146755586\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLAND\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Gland Pharma&#8217;s<\/a><\/strong> revenue rose by 33% YoY from Rs. 931.3 Cr in Q1 FY23 to Rs. 1246.2 Cr in Q1 FY24 and a 51% increase in revenue QoQ from Rs. 824 Cr in Q4 FY23 to Rs. 1246.2 Cr in Q1 FY24. Earning Before Interest &amp; Tax Depreciation and Amortization (EBITDA) increased by 10% from Rs. 2,69.9 Cr in Q1 FY23 to Rs. 298.2 Cr in Q1 FY24.<\/p><p>Net profits increased by 147% quarter on quarter from RS. 78.7 Cr in Q4 FY23 to Rs. 194.1 Cr in Q1 FY24 but a 15% decline in net profit year on year from Rs. 2,29.2 Cr in Q1 FY23 to Rs. 194.1 Cr in Q1 FY24.&nbsp;<\/p><p>The company&#8217;s Spending on research and development has improved by 11% from Rs. 41 Cr in Q1 FY23 to Rs. 45.7% in Q1 FY24. During the same quarter, the company filled 5 ANDAs ( Abbreviated New Drug Application) and received approval for 9 ANDAs.<\/p><div class=\"trade-content_5\" id=\"trade-163528602\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>As of June 2023, Parmoters own 57.86%, DIIs hold 23.38%, FIIs hold 2.80%, and Retail &amp; Others hold a 15.96% stake in this company.<\/p><p>Since its establishment in Hyderabad, India, in 1978, Gland Pharma has developed from a contract manufacturer of low-volume liquid parenteral products to one of the largest and fastest-growing manufacturers of generic injectables, with a presence in more than 60 nations worldwide, including the United States, Europe, Canada, Australia, India, and other markets.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By Sheshadri N<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-607782916\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#8217;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes. Gland Pharma&#8217;s revenue rose by 33% YoY from Rs. 931.3 Cr in Q1 FY23 to [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[4267,10656,9339,9157,5890,948,936,10657],"class_list":["post-106378","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-gland-pharma-limited","tag-gland-pharma-q1-results-2023","tag-gland-pharma-share-price","tag-pharma-stock-2023","tag-pharma-stocks-latest-news","tag-stock-market","tag-stock-market-news","tag-why-is-gland-pharma-share-going-up"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 20% upper circuit after company&#039;s net profit increases by 147% - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#039;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#039;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 20% upper circuit after company&#039;s net profit increases by 147%\" \/>\n<meta property=\"og:description\" content=\"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#039;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday&#039;s stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-08T07:19:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-08T07:19:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/\",\"name\":\"Pharma stock hits 20% upper circuit after company's net profit increases by 147% - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-08-08T07:19:19+00:00\",\"dateModified\":\"2023-08-08T07:19:21+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 20% upper circuit after company&#8217;s net profit increases by 147%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 20% upper circuit after company's net profit increases by 147% - Trade Brains Features","description":"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 20% upper circuit after company's net profit increases by 147%","og_description":"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-08T07:19:19+00:00","article_modified_time":"2023-08-08T07:19:21+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/","name":"Pharma stock hits 20% upper circuit after company's net profit increases by 147% - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-08-08T07:19:19+00:00","dateModified":"2023-08-08T07:19:21+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.A mid-cap firm, the company has a market value of Rs. 26,534 Cr. Tuesday's stock price touched a 20% upper circuit at Rs. 1,611.05 per share after starting the day at Rs. 1500. The explanation for these Q1 FY24 outcomes.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-companys-net-profit-increases-by-147\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 20% upper circuit after company&#8217;s net profit increases by 147%"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=106378"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106378\/revisions"}],"predecessor-version":[{"id":106381,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/106378\/revisions\/106381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=106378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=106378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=106378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}